DK1567529T3 - Pseudopolymorfe former af en hiv-proteaseinhibitor - Google Patents

Pseudopolymorfe former af en hiv-proteaseinhibitor

Info

Publication number: DK1567529T3
Authority: DK; Denmark
Prior art keywords: protease inhibitor; hiv protease; pseudopolymorph forms; pseudopolymorph; forms
Prior art date: 2002-05-16

Application number

DK03753571.3T

Other languages

English (en)

Other versions

DK1567529T4 (da

Inventor

Hans Wim Pieter Vermeersch

Luc Donné Marie-Louise Janssens

Piet Bert Paul Wigerinck

Daniel Joseph Christiaan Thone

Original Assignee

Janssen R & D Ireland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-16

Filing date

2003-05-16

Publication date

2014-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29724454&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1567529(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-05-16 Application filed by Janssen R & D Ireland filed Critical Janssen R & D Ireland

2014-09-15 Application granted granted Critical

2014-09-15 Publication of DK1567529T3 publication Critical patent/DK1567529T3/da

2021-05-10 Publication of DK1567529T4 publication Critical patent/DK1567529T4/da

Links

229940122440 HIV protease inhibitor Drugs 0.000 title 1
239000004030 hiv protease inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Furan Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK03753571.3T 2002-05-16 2003-05-16 Pseudopolymorfe former af en hiv-proteaseinhibitor DK1567529T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP02076929		2002-05-16
PCT/EP2003/050176 WO2003106461A2 (en)	2002-05-16	2003-05-16	Pseudopolymorphic forms of a hiv protease inhibitor

Publications (2)

Publication Number	Publication Date
DK1567529T3 true DK1567529T3 (da)	2014-09-15
DK1567529T4 DK1567529T4 (da)	2021-05-10

Family

ID=29724454

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK14168686.5T DK2767539T3 (da)	2002-05-16	2003-05-16	Pseudopolymorfe former af en HIV-proteasehæmmer
DK03753571.3T DK1567529T4 (da)	2002-05-16	2003-05-16	Pseudopolymorfe former af en hiv-proteaseinhibitor
DK10180831.9T DK2314591T4 (da)	2002-05-16	2003-05-16	Pseudopolymorfe former af en HIV-proteasehæmmer

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK14168686.5T DK2767539T3 (da)	2002-05-16	2003-05-16	Pseudopolymorfe former af en HIV-proteasehæmmer

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK10180831.9T DK2314591T4 (da)	2002-05-16	2003-05-16	Pseudopolymorfe former af en HIV-proteasehæmmer

Country Status (25)

Country	Link
US (8)	US7700645B2 (da)
EP (4)	EP2314591B2 (da)
JP (1)	JP4864320B2 (da)
KR (2)	KR20100119906A (da)
CN (1)	CN100475819C (da)
AP (1)	AP2052A (da)
AU (2)	AU2003271740B2 (da)
BR (1)	BRPI0311176B8 (da)
CA (1)	CA2485834C (da)
CY (3)	CY1117928T1 (da)
DK (3)	DK2767539T3 (da)
EA (1)	EA007120B8 (da)
ES (4)	ES2503551T5 (da)
HR (1)	HRP20041061B1 (da)
HU (1)	HUE034389T2 (da)
IL (1)	IL165140A0 (da)
LT (1)	LT2767539T (da)
MX (1)	MXPA04011427A (da)
NO (1)	NO331477B1 (da)
NZ (1)	NZ536497A (da)
PL (1)	PL215151B1 (da)
PT (3)	PT2314591E (da)
SI (3)	SI1567529T2 (da)
WO (1)	WO2003106461A2 (da)
ZA (1)	ZA200410154B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4776775B2 (ja)	1998-06-23	2011-09-21	アメリカ合衆国	Ｈｉｖ感染哺乳動物を治療するための医薬組成物
ES2503551T5 (es)	2002-05-16	2021-10-28	Janssen Sciences Ireland Unlimited Co	Formas pseudopolimórficas de un inhibidor de la proteasa de VIH
HRP20020614A2 (en) *	2002-07-22	2004-06-30	PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o.	Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
RS51073B (sr)	2003-12-23	2010-10-31	Tibotec Pharmaceuticals Ltd.	Proces za pripremanje (3r,3as,6ar)-heksahidrofuro│2,3-b│ furan-3-il (1s,2r)-3-││(4-aminofenil) sulfonil│(izobutil) amino │-1-benzil-2-hidroksipropilkarbamata
AU2006217922B2 (en)	2005-02-25	2012-04-05	Janssen Sciences Ireland Uc	Protease inhibitor precursor synthesis
ES2359949T3 (es) *	2006-11-09	2011-05-30	Tibotec Pharmaceuticals	Métodos para preparar hexhidrofuro(2,3-b)furan-3-ol.
AR073248A1 (es)	2008-09-01	2010-10-20	Tibotec Pharm Ltd	Proceso para la preparacion de (1s, 2r)-3- ((4-aminofenil) sulfonil) ( isobutil) amino)-1- bencil-2- hidroxipropilcarbamato de (3r, 3as,6ar)- hexahidrofuro-(2,3-b) furan-3- ilo (darunavir) y compuestos intermediarios utiles en dicho proceso.
US8921415B2 (en)	2009-01-29	2014-12-30	Mapi Pharma Ltd.	Polymorphs of darunavir
US20120035142A1 (en) *	2009-01-29	2012-02-09	Mapi Pharma Limited	Polymorphs of darunavir
WO2011048604A2 (en) *	2009-09-17	2011-04-28	Matrix Laboratories Limited	An improved process for the preparation of darunavir
WO2011051978A2 (en)	2009-10-30	2011-05-05	Lupin Limited	A novel process for preparation of darunavir and darunavir ethanolate of fine particle size
ES2546866T3 (es) *	2009-12-16	2015-09-29	Hetero Research Foundation	Polimorfos de darunavir
AU2010340799B2 (en) *	2010-01-05	2015-06-11	Cipla Limited	Darunavir polymorph and process for preparation thereof
EP2528923B1 (en)	2010-01-28	2014-07-30	Mapi Pharma Limited	Process for the preparation of darunavir and darunavir intermediates
EP2571355B1 (en)	2010-05-20	2016-09-07	Hetero Research Foundation	Crystalline hydrochloride salt of darunavir
WO2012107889A1 (en)	2011-02-10	2012-08-16	Ranbaxy Laboratories Limited	Process for the preparation of amorphous darunavir
SI2729130T1 (en)	2011-07-07	2018-03-30	Janssen Sciences Ireland Uc	Combined formulations of darunavir
WO2013114382A1 (en)	2011-12-05	2013-08-08	Mylan Laboratories Ltd	Crystalline darunavir
WO2013108105A2 (en) *	2012-01-18	2013-07-25	Aurobindo Pharma Limited	Novel solvates of darunavir
CN103509031B (zh) *	2012-06-20	2016-04-27	上海迪赛诺药业有限公司	制备达芦那韦无定形物的方法
ES2848216T3 (es) *	2012-07-24	2021-08-05	Laurus Labs Ltd	Un proceso para la preparación de Darunavir
WO2014068265A1 (en)	2012-10-29	2014-05-08	Cipla Limited	Antiviral phosphonate analogues and process for preparation thereof
US9346820B2 (en) *	2013-09-11	2016-05-24	Purdue Research Foundation	HIV-1 protease inhibitors having gem-di-fluoro bicyclic P2-ligands
WO2016092525A1 (en) *	2014-12-12	2016-06-16	Lupin Limited	Darunavir n-propanol solvate and process for preparation thereof
WO2016092527A1 (en) *	2014-12-12	2016-06-16	Sun Pharmaceutical Industries Limited	A process for the preparation of dolutegravir
PL3271347T3 (pl) *	2015-03-19	2022-11-21	Mycovia Pharmaceuticals, Inc.	Związki przeciwgrzybicze i sposoby wytwarzania
US20190175511A1 (en)	2016-08-08	2019-06-13	Hetero Labs Limited	A Multi-Class Anti-Retroviral Composition
US11045423B2 (en)	2016-08-08	2021-06-29	Hetero Labs Limited	Anti-retroviral compositions
US10407438B2 (en)	2016-10-27	2019-09-10	Gilead Sciences, Inc.	Crystalline forms of darunavir
CN108727401A (zh) *	2017-04-20	2018-11-02	盐城迪赛诺制药有限公司	达鲁那韦新晶型及其制备方法和应用
CN109053753A (zh) *	2018-08-05	2018-12-21	浙江大学	一种制备达卢那韦二水合物晶型的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5413999A (en) *	1991-11-08	1995-05-09	Merck & Co., Inc.	HIV protease inhibitors useful for the treatment of AIDS
JPH05230044A (ja)	1992-02-21	1993-09-07	Hoechst Japan Ltd	ピレタニドの新規な結晶多形
US5968942A (en) *	1992-08-25	1999-10-19	G. D. Searle & Co.	α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
AU7669794A (en) *	1993-08-24	1995-03-21	G.D. Searle & Co.	Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
CN1072215C (zh) *	1995-02-22	2001-10-03	赫彻斯特药品和化学品公司	无定形吡咯他尼、吡咯他尼多晶型物,其制备方法和用途
CO4940492A1 (es) *	1997-05-29	2000-07-24	Merck & Co Inc	Inhibidor de proteasa de vih
GB9712253D0 (en)	1997-06-13	1997-08-13	Glaxo Group Ltd	Antiviral compound
US6287693B1 (en) *	1998-02-25	2001-09-11	John Claude Savoir	Stable shaped particles of crystalline organic compounds
GB9805898D0 (en) *	1998-03-20	1998-05-13	Glaxo Group Ltd	Process for the sythesis of hiv protease inhibitors
GB9807354D0 (en)	1998-04-07	1998-06-03	Glaxo Group Ltd	Antiviral compound
JP4776775B2 (ja)	1998-06-23	2011-09-21	アメリカ合衆国	Ｈｉｖ感染哺乳動物を治療するための医薬組成物
WO1999067254A2 (en) *	1998-06-23	1999-12-29	The United States Of America Represented By The Secretary, Department Of Health And Human Services	Multi-drug resistant retroviral protease inhibitors and use thereof
WO2000029390A1 (en)	1998-11-19	2000-05-25	Du Pont Pharmaceuticals Company	Crystalline (-)-6- chloro-4- cyclopropylethynyl- 4-trifluoromethyl- 3,4-dihydro- 2(1h)-quinazolinone
EP1159278B1 (en)	1999-02-12	2005-11-30	Vertex Pharmaceuticals Incorporated	Inhibitors of aspartyl protease
ES2503551T5 (es)	2002-05-16	2021-10-28	Janssen Sciences Ireland Unlimited Co	Formas pseudopolimórficas de un inhibidor de la proteasa de VIH
AU2010340799B2 (en) *	2010-01-05	2015-06-11	Cipla Limited	Darunavir polymorph and process for preparation thereof

2003
- 2003-05-16 ES ES10180831T patent/ES2503551T5/es not_active Expired - Lifetime
- 2003-05-16 DK DK14168686.5T patent/DK2767539T3/da active
- 2003-05-16 AP AP2004003191A patent/AP2052A/xx active
- 2003-05-16 AU AU2003271740A patent/AU2003271740B2/en not_active Revoked
- 2003-05-16 LT LTEP14168686.5T patent/LT2767539T/lt unknown
- 2003-05-16 ES ES03753571T patent/ES2498370T5/es not_active Expired - Lifetime
- 2003-05-16 EP EP10180831.9A patent/EP2314591B2/en not_active Expired - Lifetime
- 2003-05-16 WO PCT/EP2003/050176 patent/WO2003106461A2/en not_active Ceased
- 2003-05-16 PT PT101808319T patent/PT2314591E/pt unknown
- 2003-05-16 EA EA200401503A patent/EA007120B8/ru unknown
- 2003-05-16 CN CNB038164590A patent/CN100475819C/zh not_active Expired - Lifetime
- 2003-05-16 CA CA002485834A patent/CA2485834C/en not_active Expired - Lifetime
- 2003-05-16 KR KR1020107024106A patent/KR20100119906A/ko not_active Ceased
- 2003-05-16 SI SI200332389T patent/SI1567529T2/sl unknown
- 2003-05-16 BR BRPI0311176A patent/BRPI0311176B8/pt active IP Right Grant
- 2003-05-16 DK DK03753571.3T patent/DK1567529T4/da active
- 2003-05-16 DK DK10180831.9T patent/DK2314591T4/da active
- 2003-05-16 PT PT37535713T patent/PT1567529E/pt unknown
- 2003-05-16 MX MXPA04011427A patent/MXPA04011427A/es active IP Right Grant
- 2003-05-16 ES ES14168686.5T patent/ES2638412T3/es not_active Expired - Lifetime
- 2003-05-16 SI SI200332383T patent/SI2314591T2/sl unknown
- 2003-05-16 ES ES16158480T patent/ES2728735T3/es not_active Expired - Lifetime
- 2003-05-16 EP EP16158480.0A patent/EP3045460B1/en not_active Expired - Lifetime
- 2003-05-16 EP EP14168686.5A patent/EP2767539B1/en not_active Expired - Lifetime
- 2003-05-16 EP EP03753571.3A patent/EP1567529B2/en not_active Expired - Lifetime
- 2003-05-16 NZ NZ536497A patent/NZ536497A/en not_active IP Right Cessation
- 2003-05-16 HR HRP20041061AA patent/HRP20041061B1/hr not_active IP Right Cessation
- 2003-05-16 PL PL374321A patent/PL215151B1/pl unknown
- 2003-05-16 SI SI200332545T patent/SI2767539T1/sl unknown
- 2003-05-16 JP JP2004513292A patent/JP4864320B2/ja not_active Expired - Lifetime
- 2003-05-16 US US10/514,352 patent/US7700645B2/en active Active
- 2003-05-16 HU HUE14168686A patent/HUE034389T2/en unknown
- 2003-05-16 KR KR1020047018426A patent/KR101128370B1/ko not_active Expired - Lifetime
- 2003-05-16 PT PT141686865T patent/PT2767539T/pt unknown
2004
- 2004-11-10 IL IL16514004A patent/IL165140A0/xx unknown
- 2004-12-10 NO NO20045409A patent/NO331477B1/no not_active IP Right Cessation
- 2004-12-15 ZA ZA2004/10154A patent/ZA200410154B/en unknown
2009
- 2009-08-06 US US12/536,807 patent/US8518987B2/en not_active Expired - Fee Related
2012
- 2012-07-03 AU AU2012205289A patent/AU2012205289A1/en active Pending
2013
- 2013-07-11 US US13/939,494 patent/US20130303790A1/en not_active Abandoned
2014
- 2014-02-19 US US14/183,712 patent/US20140171499A1/en not_active Abandoned
- 2014-09-17 CY CY20141100756T patent/CY1117928T1/el unknown
- 2014-09-17 CY CY20141100755T patent/CY1115665T1/el unknown
2015
- 2015-08-04 US US14/817,827 patent/US20150336980A1/en not_active Abandoned
2017
- 2017-05-22 US US15/600,932 patent/US10000504B2/en not_active Expired - Lifetime
- 2017-08-23 CY CY20171100896T patent/CY1119311T1/el unknown
2018
- 2018-05-16 US US15/980,993 patent/US10858369B2/en not_active Expired - Lifetime
2020
- 2020-10-30 US US17/085,096 patent/US20210179631A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO331477B1 (no)	2012-01-16
HUE034389T2 (en)	2018-02-28
NO20045409L (no)	2004-12-10
AP2052A (en)	2009-10-05
EP3045460A1 (en)	2016-07-20
EA200401503A1 (ru)	2005-06-30
CA2485834A1 (en)	2003-12-24
SI2314591T2 (sl)	2021-08-31
US20050250845A1 (en)	2005-11-10
US10858369B2 (en)	2020-12-08
US8518987B2 (en)	2013-08-27
CY1115665T1 (el)	2017-01-25
AU2003271740B2 (en)	2010-05-13
KR20100119906A (ko)	2010-11-11
EA007120B1 (ru)	2006-06-30
SI1567529T1 (sl)	2014-11-28
AP2004003191A0 (en)	2004-12-31
LT2767539T (lt)	2017-09-25
IL165140A0 (en)	2005-12-18
EP2767539A1 (en)	2014-08-20
WO2003106461A3 (en)	2004-05-13
EP2314591B1 (en)	2014-06-18
PT2767539T (pt)	2017-08-28
ES2498370T5 (es)	2021-11-24
CY1117928T1 (el)	2017-05-17
EP1567529B2 (en)	2021-02-24
EP1567529B1 (en)	2014-06-18
ES2498370T3 (es)	2014-09-24
HK1081969A1 (en)	2006-05-26
PT2314591E (pt)	2014-09-19
US20100204316A1 (en)	2010-08-12
AU2012205289A1 (en)	2012-08-09
HRP20041061A2 (en)	2006-07-31
BR0311176A (pt)	2005-03-15
CA2485834C (en)	2007-07-17
US20130303790A1 (en)	2013-11-14
SI2314591T1 (sl)	2014-11-28
DK1567529T4 (da)	2021-05-10
EP3045460B1 (en)	2019-04-17
PL215151B1 (pl)	2013-10-31
EP1567529A2 (en)	2005-08-31
KR101128370B1 (ko)	2012-04-23
WO2003106461A2 (en)	2003-12-24
BRPI0311176B8 (pt)	2021-05-25
PL374321A1 (en)	2005-10-17
NZ536497A (en)	2006-08-31
EP2314591A1 (en)	2011-04-27
KR20050008715A (ko)	2005-01-21
DK2314591T4 (da)	2021-05-10
BRPI0311176B1 (pt)	2019-08-20
DK2767539T3 (da)	2017-09-11
EP2314591B2 (en)	2021-02-24
ES2503551T5 (es)	2021-10-28
EA007120B8 (ru)	2012-03-30
US20150336980A1 (en)	2015-11-26
US10000504B2 (en)	2018-06-19
US20210179631A1 (en)	2021-06-17
ES2638412T3 (es)	2017-10-20
DK2314591T3 (da)	2014-09-22
US7700645B2 (en)	2010-04-20
CN1668623A (zh)	2005-09-14
PT1567529E (pt)	2014-09-09
CY1119311T1 (el)	2018-02-14
JP4864320B2 (ja)	2012-02-01
HRP20041061B1 (hr)	2015-02-27
US20180312517A1 (en)	2018-11-01
AU2003271740A1 (en)	2003-12-31
EP2767539B1 (en)	2017-07-12
SI2767539T1 (sl)	2017-10-30
US20140171499A1 (en)	2014-06-19
ZA200410154B (en)	2005-12-28
ES2728735T3 (es)	2019-10-28
SI1567529T2 (sl)	2021-08-31
CN100475819C (zh)	2009-04-08
US20170260196A1 (en)	2017-09-14
JP2005533068A (ja)	2005-11-04
ES2503551T3 (es)	2014-10-07
MXPA04011427A (es)	2005-02-17

Publication	Publication Date	Title
DK2314591T3 (da)	2014-09-22	Pseudopolymorfe former af en HIV-proteasehæmmer
DK1458447T3 (da)	2010-01-18	Kombination af cytokrom-p450-beroende proteasinhibitorer
CY2015028I1 (el)	2016-07-27	Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
JP2005511541A5 (ja)	2006-01-05	プロリン後切断プロテアーゼの阻害剤
DK1505963T3 (da)	2011-08-08	Hepatitis C-inhibitorer
EP1499336A4 (en)	2005-06-01	PROTEASE INHIBITORS
DK1483284T3 (da)	2006-10-16	Selektive dipeptidinhibitorer af kallikrein
NO20042080L (no)	2004-07-16	Inhibitorer for post-prolin spaltningsproteaser
FR15C0028I2 (fr)	2015-11-13	Fabrication de tiacumicine
DE60234125D1 (de)	2009-12-03	E inhibitoren
CY2012007I2 (el)	2014-07-02	Πεπτιδομιμητικοι αναστολεις πρωτεασης
PL367337A1 (pl)	2005-02-21	Przenikająca przez skórę kompozycja selektywnego inhibitora cyklooksygenazy-2
NO20044258L (no)	2004-10-28	Cystein proteaseinhibitor
EP1474093A4 (en)	2005-02-16	Granzyme B INHIBITORS
DK1686113T3 (da)	2012-02-20	Inhibitorer af aspartylprotease
DK1470732T3 (da)	2019-12-02	Fremskaffelse af lokaliseringsinformation
DE60215623D1 (de)	2006-12-07	Breitspektrum 2-(substituierte-amino)-benzothiazol-sulfonamide hiv protease inhibitoren
DK1451154T3 (da)	2008-05-19	Inhibitorer af cytosolisk phospholipase A2
DK1536796T3 (da)	2008-06-09	N-arylpiperidinsubstituerede biphenylcarboxamider som inhibitorer af apolipoprotein B-sektion
FI20010558L (fi)	2002-09-20	Kappaleiden paikannus
ATE429431T1 (de)	2009-05-15	2-amino-benzoxazol-suphonamide als breitspektrum- hiv-protease-inhibitoren
EP1667973A4 (en)	2010-01-27	QUINOLINE POTASSIUM CHANNEL INHIBITORS
NO20025786D0 (no)	2002-12-02	Protaseinhibitorer
EP1558276A4 (en)	2006-09-13	FLAVIVIRIS FUSION INHIBITORS
DK1517899T3 (da)	2007-12-03	Bredspektret substitueret benzisoxazolsulfonamid HIV-proteaseinhibitor